Therefore, we also performed transwell assays (with and without matrigel) and confirmed that elevated FSTL3 expression was able to strengthen the migrative and invasive capacity of CRC cells in vitro (Figures 2D,E). This evidence concerns the gene FSTL3 and colorectal carcinoma.